Company Filing History:
Years Active: 1996-1997
Title: Ivan De Scheerder: Innovator in Vascular Technology
Introduction
Ivan De Scheerder, an inventive mind residing in St. Martens Latem, Belgium, has contributed significantly to the field of vascular technology. With two patents to his name, he focuses on developing advanced solutions that enhance medical treatments related to blood vessels. His work embodies a blend of medical innovation and engineering expertise.
Latest Patents
Ivan's latest patents include a radially expandable stent designed specifically for use in blood vessels. This invention is particularly noteworthy as it ensures that the length of the stent after expansion remains substantially the same as its original length. The stent is uniquely designed with a multi-loop configuration that is formed by annealing the wire at high temperatures. This process creates concentric bended loops that promote the stent's proper alignment within the blood vessel, thereby enhancing blood flow and minimizing thrombogenicity. Additionally, another patent underscores the same core concept by allowing stent deformation at relatively low pressures, enabling it to conform seamlessly to various blood vessel shapes and diameters.
Career Highlights
Currently, Ivan is affiliated with Global Therapeutics, LLC, where he continues to explore innovative solutions for vascular treatments. His dedication to advancing medical technology is evident in his work and the patents he has secured, contributing to the improvement of patient care in cardiovascular health.
Collaborations
During his career, Ivan has had the opportunity to work alongside talented individuals, including his coworker Joseph B Horn. Their collaboration underscores the importance of teamwork in driving innovation and tackling complex medical challenges.
Conclusion
Ivan De Scheerder stands out as a noteworthy inventor in the field of vascular technology. His latest patents reflect a commitment to enhancing medical devices, ensuring that treatments are not only effective but also safer for patients. As he continues to innovate at Global Therapeutics, LLC, his contributions will undoubtedly lead to further advancements in the medical industry.